CAS RN: 21120-91-2
1-Bromobenzocyclobutene
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250526
1g / 5g / 10g
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 21120-91-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
21120-91-2 / 7-bromobicyclo[4.2.0]octa-1,3,5-triene
Standard CAS: 21120-91-2
Multi CAS: No
Basic Information
copy
CAS
21120-91-2 copy
Multi CAS
No copy
Molecular Formula
C8H7Br copy
Molecular Weight
183.040000 copy
Exact Mass
181.973110 copy
SMILES
C1C(C2=CC=CC=C21)Br copy
InChI
InChI=1S/C8H7Br/c9-8-5-6-3-1-2-4-7(6)8/h1-4,8H,5H2 copy
InChIKey
AYNXHFRDABNHRX-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.25 copy
Molar refractivity
41.81 copy
TPSA
0.0000 copy
LogP / Solubility
WLOGP
2.68 copy
MLOGP
2.36 copy
XLogP3
2.1 copy
Consensus LogP
2.38 copy
Log S (ESOL)
-3.16 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-3.07 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.93 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
2 copy